GlassScriptPhysician profile
Chetan Sati
NPI 1699833343
$14,423.42
in general payments reported to CMS, 2019-2025
58 companies · $3,303 in 2025
The $3,303 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,330 · 2020: $1,420 · 2021: $1,717 · 2022: $2,108 · 2023: $2,067 · 2024: $2,479 · 2025: $3,303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,816 · Education: $32.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,816.40 |
| Education | $32.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,775.87 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $1,722.64 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Novo Nordisk INC | $1,257.94 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $1,254.50 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $999.88 | 2019-2025 | |
| Abbvie INC. | $962.93 | 2020-2025 | Qulipta, Ubrelvy |
| Otsuka America Pharmaceutical, INC. | $660.68 | 2022-2025 | Rexulti |
| Merck Sharp & Dohme LLC | $548.58 | 2019-2025 | Verquvo, Gardasil 9, Capvaxive |
| Medtronic, INC. | $431.17 | 2022-2025 | Kyphon Express II Kyphopak Tray, Osteocool Rf Ablation System, Venaseal |
| Currax Pharmaceuticals LLC | $410.72 | 2021-2025 | Contrave, Nexletol, Nexlizet |
| Lundbeck LLC | $391.99 | 2023-2025 | Rexulti |
| Axsome Therapeutics, INC. | $318.02 | 2023-2025 | Auvelity |
| Amarin Pharma, INC. | $278.42 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $240.85 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $239.77 | 2019-2025 | Jardiance, Synjardy |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $201.93 | 2021-2025 | Nexletol |
| Boston Scientific Corporation | $188.90 | 2021-2023 | Watchman Access System, Varithena Administration Pack |
| Exact Sciences Corporation | $182.32 | 2023-2025 | Cologuard Collection Kit |
| Genzyme Corporation | $165.97 | 2024-2025 | |
| Amgen INC. | $164.42 | 2019-2024 | Repatha, Otezla |
| Astellas Pharma US INC | $150.51 | 2021-2025 | Veozah |
| Neuronetics, INC. | $147.41 | 2022 | |
| Baxter Healthcare | $132.03 | 2024-2025 | Hillrom - Connex Spot Monitor, Hillrom - Retinavue 700 Imager |
| Daiichi Sankyo INC. | $125.23 | 2019-2024 | Injectafer |
| Regeneron Healthcare Solutions, INC. | $114.01 | 2024-2025 | Dupixent |
| Renalytix Ai, INC. | $112.88 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Abbott Laboratories | $100.87 | 2019-2023 | Freestyle Libre 2, Freestyle Libre 3 |
| Jazz Pharmaceuticals INC. | $96.61 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $88.87 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $84.50 | 2019-2022 | |
| Shield Therapeutics INC | $83.73 | 2023-2025 | Accrufer |
| Allergan, INC. | $73.09 | 2020 | |
| Eisai INC. | $71.76 | 2024-2025 | |
| Idorsia Pharmaceuticals US INC | $60.14 | 2023 | Quviviq |
| Novartis Pharmaceuticals Corporation | $53.40 | 2019-2021 | |
| Corcept Therapeutics | $44.58 | 2024 | Korlym |
| Phadia US INC. | $39.68 | 2024-2025 | Immunocap |
| Inspire Medical Systems, INC. | $31.96 | 2023 | Inspire |
| Stryker Corporation | $30.69 | 2023 | Ortholoc 3di |
| Advanced Oxygen Therapy INC. | $28.03 | 2022 | |
| Convatec INC. | $27.23 | 2021 | |
| Lifenet Health | $25.23 | 2024 | Theragenesis Wound Matrix |
| Janssen Biotech, INC. | $24.51 | 2021 | |
| Abiomed | $24.33 | 2023 | Impella |
| Avvisto Therapeutics, LLC | $24.12 | 2024 | Cycloset |
| Ardelyx, INC. | $22.62 | 2025 | Ibsrela |
| Avanir Pharmaceuticals, INC. | $22.30 | 2019 | |
| Grifols USA, LLC | $22.23 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.44 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.79 | 2025 | |
| Horizon Therapeutics Plc | $19.08 | 2022 | |
| Sanofi-Aventis U.S. LLC | $17.37 | 2019 | |
| Shire North American Group INC | $17.10 | 2019 | |
| Melinta Therapeutics, LLC | $17.02 | 2019 | |
| Verona Pharma, INC. | $16.21 | 2025 | Ohtuvayre |
| Hikma Pharmaceuticals USA | $12.98 | 2021 | |
| Glenmark Therapeutics INC. | $12.00 | 2019 | |
| Zyla Life Sciences, INC. | $11.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chetan Sati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.